Secondary prevention with beta-blockers after myocardial infarction
Tidsskr Nor Laegeforen. 2026 Jan 30;146(2).
doi: 10.4045/tidsskr.25.0735.
Print 2026 Feb 10.
[Article in
English,
Norwegian]
Authors
John Munkhaugen, Arnhild Bakken, Anna Meta Dyrvig Kristiansen
1
, Thor Edvardsen, Rune Wiseth, Terje Kristian Steigen, Henrik Schirmer, Alf-Inge Larsen, Jarle Jortveit, Kjell Vikenes, Sigrun Halvorsen, Dan Atar
Affiliation
- 1 Anna Meta Dyrvig Kristiansen er lege og ph.d.-stipendiat ved Københavns Universitetshospital.
No abstract available
Plain language summary
Recent studies and meta-analyses show that treatment with beta-blockers improves prognosis after myocardial infarction in patients with mildly reduced left ventricular function, but not in patients with normal function who have no other indications for beta-blockers. The results of these new studies will be incorporated into future guidelines and are likely to inform clinical practice worldwide.